MedPath

PERGOVERIS

PERGOVERIS

Approved
DIN Number

02470640

Drug Class

Human

Market Date

Oct 21, 2021

Company
HC

emd serono, a division of emd inc., canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02470640
AIG Number0257310002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
G03GA30 COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:18.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

FOLLITROPIN ALFAActive
Strength: 300 UNIT / 0.48 ML
Monograph: FOLLITROPIN ALFA
LUTROPIN ALFAActive
Strength: 150 UNIT / 0.48 ML
Monograph: LUTROPIN ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.